Mycophenolate Sodium Enteric-Coated Tablets Versus Mycophenolate Mofetil for Inhibition of Bone Marrow in Renal Transplant Repicients

张岩,何龙,范连慧,张培敏,王军,刘龙,史国兵,李昕
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2014.03.002
2014-01-01
Abstract:Objective To observe the bone marrow suppression of kidney transplant recipients after using mycophenolate sodium enteric-coated tablets (EC-MPS) versus mycophenolate mofetil (MMF).Method From January 2008 to the end of December 2012,102 cases of kidney transplant recipients were assigned into groups by random number method.Both of EC-MPS and MMF groups had 51 cases,and the immunosuppressive regimen was composed of cyclosporine A + EC-MPS (or MMF) + prednisone.The bone marrow suppression after application of two therapeutic regimens was observed,and the therapeutic effect was evaluated.Result EC-MPS group recipients had stronger hemoglobin inhibition than MMF group (P =0.045 4).The platelet functions in MMF group were inhibited more significantly than EC-MPS group (P =0.001 6).There was no statistically significant difference between EC-MPS and MMF group in leukocyte inhibition (P =0.167 4).Conclusion EC-MPS and MMF have some differences in bone marrow suppression of kidney transplant recipients,and for some patients the particular case should be concerned before making a choice.
What problem does this paper attempt to address?